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Abstract
We assessed the accuracy of the Centers for Disease Control
and Prevention (CDC) clinical criteria as well as other microbio-
logical methods for the diagnosis of coagulase-negative staphylo-
cocci bacteraemia. The CDC clinical criteria had low accuracy,
which can be improved by speciation, particularly if the patient
had more than two positive blood cultures.
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Coagulase-negative staphylococci (CoNS) are the most com-
mon cause of health care-associated bloodstream infections
[1,2], partly because of the increased use of indwelling medi-
cal devices, such as central venous catheters and other pros-
thetic materials [3,4]. However, CoNS are also common
colonizers of human skin; hence, a positive blood culture for
CoNS may represent contamination [5]. To avoid unneces-
sary catheter removal and the inappropriate use of empiric
antibiotics, it is important to differentiate CoNS bacteraemia
from contamination [6,7]. Several studies evaluated CDC
clinical criteria and showed that they correlate poorly with
genotyping, suggesting that they are an inaccurate diagnostic
method [5,8]. However, the routine use of molecular tech-
niques may impose a prohibitive cost for some laboratories.
Alternative and inexpensive diagnostic techniques are
needed. We evaluated the accuracy of the CDC clinical cri-
teria and other microbiological methods (e.g. species identiﬁ-
cation) when diagnosing CoNS bacteraemia in cancer
patients using molecular genotype matching.
This retrospective study was performed at M. D. Ander-
son Cancer Center between January 2006 and May 2008. All
patients with two or more positive blood culture sets for
CoNS within a one-week period were eligible, and their
medical records were reviewed. We determined species
speciﬁcation and genotype on available paired samples (the
ﬁrst two cultures).
Clinical data collected included age, sex, underlying dis-
ease, symptoms of infection, microbiological data, other
infection sites, and exposure to antibiotic therapy. Patients
with polymicrobial cultures were excluded.
The clinical deﬁnition of CoNS bacteraemia was based
on the CDC’s criterion [9] of ‡2 positive blood cultures
within 48 h, along with symptoms of infection (i.e. fever
>38, chills, or hypotension) that are not related to another
infection. Patients were considered to have true CoNS bac-
teraemia if they met the CDC clinical criteria and if identi-
cal species and strains were isolated from positive blood
culture sets. New CDC criteria also add same antibiograms
of isolates (http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_
clabscurrent.pdf).
We identiﬁed the bacterial strains using the VITEKI
GPIV1305 automatic identiﬁcation system (BioMerieux,
Marcy l’Etoile, France). CoNS strains were identiﬁed by gram
stain morphology, catalase positivity, staphAurex and tube
coagulation. The CoNS microbial genotype was determined
using the repetitive polymerase chain reaction (PCR) method
with the DiversiLab repetitive-PCR genotyping system (Spec-
tral Genomics, Houston, TX, USA). DNA was extracted
from an overnight culture with the UltraClean DNA isolation
kit (Mo Bio Laboratories Inc., Carlsbad, CA, USA). Bacterial
DNA was ampliﬁed using a Gene Amp PCR system 9700
(Applied Biosystems, Foster City, CA, USA) with the Diversi-
Lab Staphylococcus PCR reaction mix, which contains manu-
facturer-supplied primers for Staphylococcus strains. PCR
products were loaded on a microﬂuid device containing a
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ﬂuorescent DNA intercalating dye. The DNA fragments were
separated within micro-channels by electrophoresis on the
basis of size and detected using a laser beam. The data were
reported as a dendogram and similarity matrix, which were
used to interpret the data. We used 16sPCR and sequencing
to conﬁrm the results of indeterminate cases by VITEKI.
We compared the sensitivity, speciﬁcity, positive and neg-
ative predictive values of the CDC clinical criteria and spe-
cies identiﬁcation, separately and combined, using molecular
genotyping as the reference standard. We also estimated the
95% conﬁdence interval for the calculated sensitivity and
speciﬁcity. We compared clinical and microbiological features
between identical and different pairs using chi-square for
bivariate analysis and built logistic regression model, including
all variables with a p value for association with identical
genotype of 0.25 or less. All statistical tests were two tailed
with a level of signiﬁcance of £0.05. SAS, version 9 (SAS,
Cary, NC, USA) was used for all statistical analyses.
From January 2006 to May 2008 we identiﬁed 101 patients
with at least two CoNS-positive blood cultures with available
isolates. Most of the patients (90%) fulﬁlled the CDC’s clini-
cal criteria for bloodstream infection. Most isolate pairs
(73.2%) had identical genotypes, whereas 26.7% were differ-
ent (Table 1).
The sensitivity of the CDC clinical criteria was 91%, but
its speciﬁcity was only 11%. On the other hand, species iden-
tiﬁcation had a sensitivity of 100% and a speciﬁcity of 48%
(Table 2). The sensitivity and speciﬁcity of the CDC clinical
criteria and species identiﬁcation combined were 91% and
52%, respectively, with a PPV of 84% and NPV of 67%. The
new CDC criteria had a sensitivity of 76%, speciﬁcity of 26%,
PPV of 75% and NPV of 27%. Staphylococcus epidermidis was
the most common (86.13%) followed by Staphylococcus ho-
minis (5.94%). Most patients (98%) had a CVC in place at the
time of bacteraemia.
By multivariate analysis, patients with identical genotypes
were more likely to have more than two positive blood cul-
ture sets (55.4% vs. 29.6%; p 0.02), although, by univariate
analysis, patients with the same genotypes were more likely
to have an interval between the two blood culture sets
<72 h (18.5% vs. 5.4%; p 0.05). However, this difference was
not statistically signiﬁcant by multivariate analysis. No other
variables differed signiﬁcantly between the two groups
(Table 1).
Both CDC clinical criteria are sensitive for the primary
diagnosis of CoNS bacteraemia; however, in our study, many
patients met the CDC clinical criteria but had genotypically
different isolated bacterial strains. Seo et al. [10] and Senger
et al. [11] found that the CDC clinical criteria correlated
poorly with molecular genotyping. Thus, based on our data,
we recommend using the CDC clinical criteria as a screening
test for bloodstream infections rather than as the ultimate
conﬁrmatory test in the setting of multiple CoNS-positive
blood cultures sets.
Species identiﬁcation is a simple and quick diagnostic tech-
nique, but it cannot always establish a ﬁnal diagnosis of
CoNS bacteraemia when used alone. The combination of the
CDC clinical criteria and species identiﬁcation was associated
with higher diagnostic accuracy than either alone, but its
speciﬁcity remained low. The limitations of molecular geno-
typing are that it is costly, time consuming, and available only
in advanced research centres.
TABLE 2. Test characteristics of the CDC’s clinical criteria
and species identiﬁcation when detecting true bacteraemia,
deﬁned as paired cultures with indistinguishable genotype
Sensitivity Speciﬁcity
PPV NPVEstimate 95% CI Estimate 95% CI
CDC criteria 91 81–96 11 2–29 74 30
Species identiﬁcation 100 95–100 48 29–68 84 100
Mixed criteria 91 81–96 52 32–71 84 67
New CDC criteria 76 65–85 26 11–46 75 27
CI, conﬁdence interval; PPV, positive predictive value; NPV, negative predictive
value.
TABLE 1. Comparison of categorical variables between
patients with identical and different genotypes
Identical,
n = 74 (%)
Different,
n = 27 (%)
p
Same speciesa 74 (100.0) 14 (51.9) <0.01
>2 positive blood culturesa 41 (55.4) 8 (29.6) 0.02
More than 72 h interval between culturesa 4 (5.4) 5 (18.5) 0.05
At least one blood culture count <10 CFUa 29 (39.2) 15 (55.6) 0.14
ICU before positive culturea 11 (14.9) 1 (3.7) 0.17
SCTa 9 (12.2) 6 (22.2) 0.22
Male sex 51 (68.9) 19 (70.4) 0.88
Nosocomial infection 37 (50.0) 11 (40.7) 0.40
Culture interval
Up to 1 h 46 (62.2) 15 (55.6) 0.82
>1 h and <1 day 13 (17.6) 6 (22.2)
‡1 day 15 (20.3) 6 (22.2)
Time to positivityb
Both <20 25 (49.0) 8 (42.1) 0.87
One <20 24 (47.1) 10 (52.6)
Both more than 20 2 (3.9) 1 (5.3)
Haematological malignancy 19 (25.7) 7 (25.9) 0.97
Sepsis symptoms 67 (90.5) 24 (88.9) 0.72
Neutropenia 35 (47.3) 13 (48.2) 0.94
Mucositis 5 (6.8) 1 (3.7) 1.00
TPN 11 (14.9) 3 (11.1) 0.75
GVHD 5 (6.8) 1 (3.7) 1.00
CVC in place 73 (98.7) 26 (96.3) 0.47
Inﬂammatory signs at CVC insertion sitec 9 (12.3) 2 (7.7) 0.72
Same antibiogramd 37 (84.1) 11 (84.6) 1.00
Prior antibiotics 47 (63.5) 16 (59.3) 0.70
ICU, intensive care unit; neutropenia, absolute neutrophil count <500; TPN,
total parenteral nutrition; SCT, stem cell transplant; GVHD, graft versus host
disease; CVC, central venous catheter.
aIncluded in multivariate analysis.
bTest was run on 70 patients.
cTest was run on 99 patients.
dTest was run on 62 patients.
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If patients had more than two positive blood culture sets
for CoNS they were more likely to have a true genotypically
proven bacteraemia by univariate and multivariate analysis.
Garcı´a [12] showed that patients with two or more blood
cultures positive for CoNS were more likely to have true
bacteraemia than those with only one; however, Seybold
et al. [13] showed that even two consecutive cultures may
represent contamination. Consequently, having more than
two positive cultures may be a good predictor for CoNS
bloodstream infection.
In conclusion, to conﬁrm the diagnosis of CoNS bactera-
emia, it is prudent for clinicians to use the CDC clinical cri-
teria along with species identiﬁcation. These combined
methods are less accurate than molecular genotyping
[10,11], yet they are rapid and available in most hospitals,
and may guide physicians in determining the right treatment
plan. More than two positive blood culture sets, if available,
may further conﬁrm the diagnosis.
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